Glucose metabolism in heart transplant recipients treated with FK506 or cyclosporine

被引：0
|
作者：
Sahar, G
Berman, M
Ben-Gal, T
Sahar, E
Kogan, A
Michowitch, R
Saute, M
Kramer, M
Sagie, A
Shapira, Y
Aravot, D
Vidne, BA
机构：
[1] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Dept Cardiothorac Surg,Heart Lung Transplant Unit, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Dept Cardiol, IL-49100 Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Pulm Inst, IL-49100 Petah Tiqwa, Israel
来源：
TRANSPLANTATION PROCEEDINGS | 2003年 / 35卷 / 02期
关键词：
D O I：
10.1016/S0041-1345(03)00095-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：678 / 678
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
    Wallemacq, PE
    Furlan, V
    Möller, A
    Schäfer, A
    Stadler, P
    Firdaous, I
    Taburet, AM
    Reding, R
    De Clety, SC
    De Goyet, JD
    Sokal, E
    Lykavieris, L
    Van Leeuw, V
    Bernard, O
    Otte, JB
    Undre, NA
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (03) : 367 - 370
  • [22] CyA to tacrolimus (FK506) conversion in liver transplant recipients
    Cuomo, O
    Iovine, L
    Carfora, T
    De Luca, M
    Di Palma, M
    Anello, R
    [J]. LIVER TRANSPLANTATION, 2004, 10 (06) : C39 - C39
  • [23] COMPARISON OF THE IMMUNOSUPPRESSIVE AND TOXIC EFFECTS OF FK506 AND CYCLOSPORINE IN XENOGRAFT RECIPIENTS
    GUDAS, VM
    CARMICHAEL, PG
    MORRIS, RE
    [J]. TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1072 - 1073
  • [24] IMMUNOSUPPRESSION SWITCH IN PEDIATRIC HEART-TRANSPLANT RECIPIENTS - CYCLOSPORINE TO FK-506
    SWENSON, JM
    FRICKER, FJ
    ARMITAGE, JM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (05) : 1183 - 1188
  • [25] Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
    P. E. Wallemacq
    V. Furlan
    A. Möller
    A. Schäfer
    P. Stadler
    I. Firdaous
    A -M. Taburet
    R. Reding
    S. Clement De Clety
    J. De Ville De Goyet
    E. Sokal
    L. Lykavieris
    V. Van Leeuw
    O. Bernard
    J. B. Otte
    N. A. Undre
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 : 367 - 370
  • [26] IMMUNOSUPPRESSION SWITCH IN PEDIATRIC HEART-TRANSPLANT RECIPIENTS - CYCLOSPORINE TO FK-506
    SWENSON, JM
    FRICKER, FJ
    ARMITAGE, JM
    CIPRIANI, LA
    WEBBER, SA
    MILLER, SA
    LAWRENCE, KS
    STARZL, TE
    [J]. CIRCULATION, 1992, 86 (04) : 363 - 363
  • [27] Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine
    Satterthwaite, R
    Aswad, S
    Sunga, V
    Shidban, H
    Bogaard, T
    Asai, P
    Khetan, U
    Akra, I
    Mendez, RG
    Mendez, R
    [J]. TRANSPLANTATION, 1998, 65 (03) : 446 - 449
  • [28] The effect of cyclosporine vs FK 506 on glucose metabolism
    Steinmueller, T
    Konrad, T
    Jonas, S
    Tullius, S
    Bechstein, WO
    Mueller, A
    Platz, KP
    Neumann, U
    Vicini, P
    Toffolo, G
    Cobelli, C
    Usadel, KH
    Neuhaus, P
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 1129 - 1130
  • [29] Kaposi's sarcoma in liver transplant recipients on FK506
    Kadry, Z
    Bronsther, O
    Fung, JJ
    [J]. TRANSPLANTATION, 1998, 65 (08) : 1140 - 1140
  • [30] Comparison of FK506 and cyclosporine - Reply
    Gjertson, DW
    Cecka, JM
    [J]. TRANSPLANTATION, 1996, 62 (05) : 702 - 702
12345